Back to Search
JANE LIESVELD, MD
MD
Hematology (Internal Medicine) Physician
NPI: 1851319610IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
147702(NY)
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
147702(NY)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
147702(NY)
CMS Specialties
PrimaryHEMATOPOIETIC CELL TRANSPLANTATION AND CELLULAR THERAPY
Additional
Education
UNIVERSITY OF IOWA, RJ & L CARVER COLLEGE OF MEDICINE
Class of 1980
Research & Publications (20)
Mixed chimerism in SCT: conflict or peaceful coexistence?
PMID 18660844·Bone Marrow Transplant·2008
6-review
Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells.
PMID 17403536·Leuk Res·2007
7-preclinical
Acute myelogenous leukemia--microenvironment interactions: role of endothelial cells and proteasome inhibition.
PMID 16321813·Hematology·2005
8-other
Effects of the farnesyl transferase inhibitor R115777 on normal and leukemic hematopoiesis.
PMID 12970780·Leukemia·2003
4-observational
Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients.
PMID 12523578·Biol Blood Marrow Transplant·2002
3-trial
Response of human CD34+ cells to CXC, CC, and CX3C chemokines: implications for cell migration and activation.
PMID 11672510·J Hematother Stem Cell Res·2001
8-other
MIP-1alpha and TGF-beta production in CD34+ progenitor-stromal cell coculture systems: effects of progenitor isolation method and cell-cell contact.
PMID 11042027·Blood Cells Mol Dis·2000
7-preclinical
Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era.
PMID 19647953·Int J Radiat Oncol Biol Phys·2010
8-other
Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization.
PMID 19483760·Bone Marrow Transplant·2010
3-trial
Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy.
PMID 19295545·Leukemia·2009
8-other
A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.
PMID 19344412·Br J Haematol·2009
3-trial
Patterns and timing of initial relapse in patients subsequently undergoing transplantation for Hodgkin's lymphoma.
PMID 19250770·Int J Radiat Oncol Biol Phys·2009
8-other
Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma.
PMID 19519691·Br J Haematol·2009
3-trial
Delivery of apoptotic signal to rolling cancer cells: a novel biomimetic technique using immobilized TRAIL and E-selectin.
PMID 19073014·Biotechnol Bioeng·2009
8-other
Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
PMID 18571721·Leuk Res·2008
3-trial
Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
PMID 18584356·Cancer Invest·2008
5-case
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.
PMID 18664621·Blood·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 601 ELMWOOD AVE, BOX MED
ROCHESTER, NY 14642 - Phone
- (585) 275-0784
Quick Facts
- NPI
- 1851319610
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 46
- Publications
- 20
Are you this provider?
Claim Your Profile